Abstract
The long-acting thyroid stimulator (LATS) has been thought to be responsible for the hyperthyroidism of Graves's disease. It is detected by its effect on the mouse thyroid gland but cannot be found in all patients with hyperthyroidism. In an attempt to clarify the problem of LATS-negative hyperthyroidism, serum was obtained from untreated patients and its effect in vitro on human thyroid tissue examined, using the activation of adenyl cyclase as a measure of stimulation. Human thyroid adenyl cyclase was activated by both thyroid-stimulating hormone (TSH) and LATS. Thyroid tissue obtained from patients with Graves's disease was relatively less responsive to LATS than was non-toxic thyroid tissue. Of the 24 samples studied five contained LATS and all of these activated adenyl cyclase. The presence of LATS protector in LATS-negative hyperthyroid patients was confirmed but LATS-negative sera had no effect on human thyroid adenyl cyclase activity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ensor J. M., Kendall-Taylor P., Munro D. S., Smith B. R. The bioassay of long-acting thyroid stimulator: a comparison of two methods. J Endocrinol. 1971 Mar;49(3):487–492. doi: 10.1677/joe.0.0490487. [DOI] [PubMed] [Google Scholar]
- Humes J. L., Rounbehler M., Kuehl F. A., Jr A new assay for measuring adenyl cyclase activity in intact cells. Anal Biochem. 1969 Nov;32(2):210–217. doi: 10.1016/0003-2697(69)90077-3. [DOI] [PubMed] [Google Scholar]
- Kendall-Taylor P. Adenyl cyclase activity in the mouse thyroid gland. J Endocrinol. 1972 Mar;52(3):533–540. doi: 10.1677/joe.0.0520533. [DOI] [PubMed] [Google Scholar]
- Kriss J. P. The long-acting thyroid stimulator and thyroid disease. Adv Intern Med. 1970;16:135–154. [PubMed] [Google Scholar]
- McKenzie J. M. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative). Metabolism. 1972 Sep;21(9):883–894. doi: 10.1016/0026-0495(72)90012-1. [DOI] [PubMed] [Google Scholar]
- Shishiba Y., Shimizu T., Yoshimura S., Shizume K. Direct evidence for human thyroidal stimulation by LATS-protector. J Clin Endocrinol Metab. 1973 Mar;36(3):517–521. doi: 10.1210/jcem-36-3-517. [DOI] [PubMed] [Google Scholar]
- Solomon D. H., Chopra I. J. Graves' disease--1972. Mayo Clin Proc. 1972 Nov;47(11):803–813. [PubMed] [Google Scholar]
- Volpe R., Edmonds M., Lamki L., Clarke P. V., Row V. V. The pathogenesis of Graves' disease. A disorder of delayed hypersensitivity? Mayo Clin Proc. 1972 Nov;47(11):824–834. [PubMed] [Google Scholar]
- Werner S. C., Wegelius O., Fierer J. A., Hsu K. C. Immunoglobulins (E,M,G) and complement in the connective tissues of the thyroid in Graves's disease. N Engl J Med. 1972 Aug 31;287(9):421–425. doi: 10.1056/NEJM197208312870901. [DOI] [PubMed] [Google Scholar]